scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Mutual Funds
ITI Pharma and Healthcare Fund Direct Growth

Feedback
ITI Pharma and Healthcare Fund Direct Growth

ITI Pharma and Healthcare Fund Direct Growth

  • Very High Risk
  • Equity
  • Sector - Healthcare
  • Share
  • Whatsapp
  • Twitter
  • Facebook
NAV as on Mar 11, 2025
i
Price per unit of the scheme.
₹ 15.9628 0.44% 1 Day Change
-3.71%
Minimum Investment ₹5000
Expense Ratio 0.43%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.
*Morningstar Rating Methodologyi

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions
 

FUND PERFORMANCE

(As On --)
Compare fund’s performance against category average across different time periods
1M 3M 6M 1Y 3Y 5Y
-- Out of -- funds in the category
Category Avg Return
--
Fund Return
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

FUND COMPARISON

This Fund
ITI Pharma and Healthcare Fund Direct Growth
VS
Equity: Sector - Healthcare Average NAV
Topper in Equity: Sector - Healthcare
All Fund
*For the other fund, rescaled NAVs are used
Share
  • Whatsapp
  • Twitter
  • Facebook

RETURN CALCULATOR

Check the return on your investment in the fund
ITI Pharma and Healthcare Fund Direct Growth
Investment Type
MONTHLY SIP ONE -TIME
Monthly Investment
Time Period (yrs)
Annual Return in %
  • Invested Amount
    ₹0
  • Return
    ₹0
  • Current Value
    ₹0

FUND SUMMARY

Benchmark
Nifty Healthcare TR INR
Expense Ratio
0.43 %
Category Avg Expense Ratio
1.00%
Minimum Investment (Lumpsum/SIP)
₹5000/₹1000
Lock In (Years)
No Lock-in
Fund Size
₹ 216.51 Cr(As on Jan, 2025)
Inception Date
Nov 11, 2021
Turnover
0.00 %
Exit Load
1% - If redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil - If redeemed or switched out after completion of 12 months from the date of allotment of units.

ABOUT THE FUND

Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

ITI Pharma and Healthcare Fund Direct Growth is an Equity - Sector - Healthcare fund. The fund was launched in Nov 11, 2021. Its risk level is Very High. The NAV of the fund as on Mar 11, 2025 is ₹15.96. Its expense ratio is 0.43 %. The fund has an AUM of ₹216.51 Cr.The fund is managed by Dhimant Shah, Rohan Korde, Tanay Gabhawala. The minimum initial investment is ₹5000 in Lumpsum mode.

SUBSCRIBE TO
BUSINESS TODAY MAGAZINE
Subscribe Now
Already a subscriber? Login

FUND MANAGER

Rohan Korde
i
Lead Fund Manager.
Nov 11, 2021- Present
  • Fund Manager Rank 6 Out of 10
    i
    Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
  • Schemes managed 12
  • Total AUM ₹ 7,929.35 Cr
  • Highest Return In 1 Yr 13.33 %
Other Funds
  • table
  • card
1M 3M 6M 1Y 3Y 5Y
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-3.71%
-3.90%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
-2.07%
-2.69%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-3.25%
-3.46%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-13.21%
-10.66%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
-12.34%
-11.17%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-17.09%
-14.86%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-11.28%
-10.93%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
-11.22%
-11.73%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-17.01%
-15.24%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
₹15.96
13.33%
11.52%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
₹17.29
-1.68%
1.37%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
₹15.63
-2.90%
0.20%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
19.34%
17.31%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
14.42%
12.63%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
18.25%
16.64%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
--
24.19%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
--
17.62%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
--
22.02%
Very High Risk
₹301.03Cr
1M 3M 6M 1Y 3Y 5Y
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -3.71%
Category Return -3.90%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -2.07%
Category Return -2.69%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -3.25%
Category Return -3.46%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -13.21%
Category Return -10.66%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -12.34%
Category Return -11.17%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -17.09%
Category Return -14.86%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -11.28%
Category Return -10.93%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -11.22%
Category Return -11.73%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -17.01%
Category Return -15.24%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return 13.33%
Category Return 11.52%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -1.68%
Category Return 1.37%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -2.90%
Category Return 0.20%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return 19.34%
Category Return 17.31%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return 14.42%
Category Return 12.63%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return 18.25%
Category Return 16.64%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return --
Category Return 24.19%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return --
Category Return 17.62%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return --
Category Return 22.02%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Dhimant Shah
Dec 1, 2022- Present
  • Schemes managed 11
  • Total AUM ₹ 7,994.45 Cr
  • Highest Return In 1 Yr 13.33 %
Other Funds
  • table
  • card
1M 3M 6M 1Y 3Y 5Y
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-3.71%
-3.90%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
-2.07%
-2.69%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-3.25%
-3.46%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-13.21%
-10.66%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
-12.34%
-11.17%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-17.09%
-14.86%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-11.28%
-10.93%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
-11.22%
-11.73%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-17.01%
-15.24%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
₹15.96
13.33%
11.52%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
₹17.29
-1.68%
1.37%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
₹15.63
-2.90%
0.20%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
19.34%
17.31%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
14.42%
12.63%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
18.25%
16.64%
Very High Risk
₹301.03Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
--
24.19%
Very High Risk
₹216.51Cr
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
--
₹17.29
--
17.62%
Very High Risk
₹364.35Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
--
22.02%
Very High Risk
₹301.03Cr
1M 3M 6M 1Y 3Y 5Y
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -3.71%
Category Return -3.90%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -2.07%
Category Return -2.69%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -3.25%
Category Return -3.46%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -13.21%
Category Return -10.66%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -12.34%
Category Return -11.17%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -17.09%
Category Return -14.86%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -11.28%
Category Return -10.93%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -11.22%
Category Return -11.73%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -17.01%
Category Return -15.24%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return 13.33%
Category Return 11.52%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return -1.68%
Category Return 1.37%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -2.90%
Category Return 0.20%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return 19.34%
Category Return 17.31%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return 14.42%
Category Return 12.63%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return 18.25%
Category Return 16.64%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return --
Category Return 24.19%
ITI Large Cap Fund Direct Growth ITI Large Cap Fund Direct Growth
Very High Risk --
  • NAV ₹17.29
  • Fund Size ₹364.35Cr
Fund Return --
Category Return 17.62%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return --
Category Return 22.02%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Tanay Gabhawala
Oct 21, 2022- Present
  • Schemes managed 10
  • Total AUM ₹ 7,871.37 Cr
  • Highest Return In 1 Yr 13.33 %
Other Funds
  • table
  • card
1M 3M 6M 1Y 3Y 5Y
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-3.71%
-3.90%
Very High Risk
₹216.51Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-3.25%
-3.46%
Very High Risk
₹301.03Cr
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
--
₹13.91
0.05%
-2.48%
Very High Risk
₹265.94Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-13.21%
-10.66%
Very High Risk
₹216.51Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-17.09%
-14.86%
Very High Risk
₹301.03Cr
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
--
₹13.91
-7.44%
-11.33%
Very High Risk
₹265.94Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
-11.28%
-10.93%
Very High Risk
₹216.51Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
-17.01%
-15.24%
Very High Risk
₹301.03Cr
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
--
₹13.91
-4.59%
-7.47%
Very High Risk
₹265.94Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
₹15.96
13.33%
11.52%
Very High Risk
₹216.51Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
₹15.63
-2.90%
0.20%
Very High Risk
₹301.03Cr
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
₹13.91
3.66%
0.71%
Very High Risk
₹265.94Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
19.34%
17.31%
Very High Risk
₹216.51Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
18.25%
16.64%
Very High Risk
₹301.03Cr
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
--
₹13.91
14.48%
15.10%
Very High Risk
₹265.94Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
--
₹15.96
--
24.19%
Very High Risk
₹216.51Cr
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
--
₹15.63
--
22.02%
Very High Risk
₹301.03Cr
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
--
₹13.91
--
15.22%
Very High Risk
₹265.94Cr
1M 3M 6M 1Y 3Y 5Y
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -3.71%
Category Return -3.90%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -3.25%
Category Return -3.46%
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
Very High Risk --
  • NAV ₹13.91
  • Fund Size ₹265.94Cr
Fund Return -0.05%
Category Return -2.48%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -13.21%
Category Return -10.66%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -17.09%
Category Return -14.86%
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
Very High Risk --
  • NAV ₹13.91
  • Fund Size ₹265.94Cr
Fund Return -7.44%
Category Return -11.33%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return -11.28%
Category Return -10.93%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -17.01%
Category Return -15.24%
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
Very High Risk --
  • NAV ₹13.91
  • Fund Size ₹265.94Cr
Fund Return -4.59%
Category Return -7.47%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return 13.33%
Category Return 11.52%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return -2.90%
Category Return 0.20%
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
Very High Risk --
  • NAV ₹13.91
  • Fund Size ₹265.94Cr
Fund Return 3.66%
Category Return 0.71%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return 19.34%
Category Return 17.31%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return 18.25%
Category Return 16.64%
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
Very High Risk --
  • NAV ₹13.91
  • Fund Size ₹265.94Cr
Fund Return 14.48%
Category Return 15.10%
ITI Pharma and Healthcare Fund Direct Growth ITI Pharma and Healthcare Fund Direct Growth
Very High Risk --
  • NAV ₹15.96
  • Fund Size ₹216.51Cr
Fund Return --
Category Return 24.19%
ITI Value Fund Direct Growth ITI Value Fund Direct Growth
Very High Risk --
  • NAV ₹15.63
  • Fund Size ₹301.03Cr
Fund Return --
Category Return 22.02%
ITI Banking and Financial Services Fund Direct Growth ITI Banking and Financial Services Fund Direct Growth
Very High Risk --
  • NAV ₹13.91
  • Fund Size ₹265.94Cr
Fund Return --
Category Return 15.22%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

DETAILED PORTFOLIO

As on Jan 2025
EQUITY (93.44%)
DEBT (0.00%)
CASH (6.56%)
Allocation by Market Cap

PERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.
  • Consistency
    i
    It represents the consistency of a fund in beating its benchmark.
  • Downside Risk
    i
    Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
  • Risk Adjusted Return
    i
    Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
  • Volatility
    i
    Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
  • Upside Capture Ratio
    i
    Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
  • Downside Capture Ratio
    i
    Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.

HISTORICAL RISK MEASURES

Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.
  • Alpha: Excess return of the fund over benchmark
    i
    Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
    1.75
    This Fund
    VS
    0.31
    Category Avg
  • Beta: Risk of the fund in relation to benchmark
    i
    Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
    0.94
    This Fund
    VS
    0.96
    Category Avg
  • Sortino Ratio: Return per unit of bad risk
    i
    A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
    1.29
    This Fund
    VS
    1.18
    Category Avg
  • R-Squared: How well the fund tracks benchmark
    i
    R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
    96.29
    This Fund
    VS
    94.94
    Category Avg
  • Sharpe Ratio: Risk adjusted return of the fund
    i
    Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
    0.79
    This Fund
    VS
    0.70
    Category Avg
  • Standard Devation: Volatility of the fund
    i
    Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
    16.13
    This Fund
    VS
    16.58
    Category Avg
Benchmark used in calculation : BSE Healthcare PR

PEER ANALYSIS

1M 3M 6M 1Y 3Y 5Y
  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
--
₹515.87
-2.26%
-3.90%
Very High Risk
₹8,160.74 Cr
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
--
₹30.64
-2.45%
-3.90%
Very High Risk
₹815.09 Cr
SBI Healthcare Opportunities Fund Direct Growth SBI Healthcare Opportunities Fund Direct Growth
--
₹450.01
-2.77%
-3.90%
Very High Risk
₹3,521.93 Cr
UTI Healthcare Fund-Growth Option- Direct UTI Healthcare Fund-Growth Option- Direct
--
₹287.97
-2.86%
-3.90%
Very High Risk
₹1,150.43 Cr
Mirae Asset Healthcare Fund Direct Growth Mirae Asset Healthcare Fund Direct Growth
--
₹38.24
-3.49%
-3.90%
Very High Risk
₹2,652.24 Cr
IDBI Healthcare Fund Direct Growth IDBI Healthcare Fund Direct Growth
--
₹29.16
-3.58%
-3.90%
Very High Risk
₹83.89 Cr
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
VERY HIGH RISK --
  • NAV ₹515.87
  • Fund Size ₹8,160.74 Cr
Fund Return -2.26%
Category Return -3.90%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
VERY HIGH RISK --
  • NAV ₹30.64
  • Fund Size ₹815.09 Cr
Fund Return -2.45%
Category Return -3.90%
SBI Healthcare Opportunities Fund Direct Growth SBI Healthcare Opportunities Fund Direct Growth
VERY HIGH RISK --
  • NAV ₹450.01
  • Fund Size ₹3,521.93 Cr
Fund Return -2.77%
Category Return -3.90%
UTI Healthcare Fund-Growth Option- Direct UTI Healthcare Fund-Growth Option- Direct
VERY HIGH RISK --
  • NAV ₹287.97
  • Fund Size ₹1,150.43 Cr
Fund Return -2.86%
Category Return -3.90%
Mirae Asset Healthcare Fund Direct Growth Mirae Asset Healthcare Fund Direct Growth
VERY HIGH RISK --
  • NAV ₹38.24
  • Fund Size ₹2,652.24 Cr
Fund Return -3.49%
Category Return -3.90%
IDBI Healthcare Fund Direct Growth IDBI Healthcare Fund Direct Growth
VERY HIGH RISK --
  • NAV ₹29.16
  • Fund Size ₹83.89 Cr
Fund Return -3.58%
Category Return -3.90%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

Top funds from this amc

1M 3M 6M 1Y 3Y 5Y
  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
ITI Conservative Hybrid Fund Direct Growth ITI Conservative Hybrid Fund Direct Growth
--
₹11.34
1.93%
1.61%
Moderate Risk
₹14.80 Cr
ITI Dynamic Bond Fund Direct Growth ITI Dynamic Bond Fund Direct Growth
--
₹12.78
0.52%
0.33%
Low to Moderate Risk
₹47.38 Cr
ITI Arbitrage Fund Direct Growth ITI Arbitrage Fund Direct Growth
--
₹13.22
0.51%
0.39%
Low Risk
₹43.18 Cr
ITI Liquid Fund Direct Growth ITI Liquid Fund Direct Growth
--
₹1,343.03
0.50%
0.42%
Low to Moderate Risk
₹80.55 Cr
ITI Banking & PSU Debt Fund Direct Gr ITI Banking & PSU Debt Fund Direct Gr
--
₹12.97
0.50%
0.23%
Low to Moderate Risk
₹30.73 Cr
ITI Ultra Short Duration Fund Direct Growth ITI Ultra Short Duration Fund Direct Growth
--
₹1,249.35
0.48%
0.42%
Low to Moderate Risk
₹317.43 Cr
ITI Conservative Hybrid Fund Direct Growth ITI Conservative Hybrid Fund Direct Growth
MODERATE RISK --
  • NAV ₹11.34
  • Fund Size ₹14.80 Cr
Fund Return 1.93%
Category Return 1.61%
ITI Dynamic Bond Fund Direct Growth ITI Dynamic Bond Fund Direct Growth
LOW TO MODERATE RISK --
  • NAV ₹12.78
  • Fund Size ₹47.38 Cr
Fund Return 0.52%
Category Return 0.33%
ITI Arbitrage Fund Direct Growth ITI Arbitrage Fund Direct Growth
LOW RISK --
  • NAV ₹13.22
  • Fund Size ₹43.18 Cr
Fund Return 0.51%
Category Return 0.39%
ITI Liquid Fund Direct Growth ITI Liquid Fund Direct Growth
LOW TO MODERATE RISK --
  • NAV ₹1,343.03
  • Fund Size ₹80.55 Cr
Fund Return 0.50%
Category Return 0.42%
ITI Banking & PSU Debt Fund Direct Gr ITI Banking & PSU Debt Fund Direct Gr
LOW TO MODERATE RISK --
  • NAV ₹12.97
  • Fund Size ₹30.73 Cr
Fund Return 0.50%
Category Return 0.23%
ITI Ultra Short Duration Fund Direct Growth ITI Ultra Short Duration Fund Direct Growth
LOW TO MODERATE RISK --
  • NAV ₹1,249.35
  • Fund Size ₹317.43 Cr
Fund Return 0.48%
Category Return 0.42%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

ABOUT THE AMC

ITI Asset Management Limited
ITI Asset Management Limited manages assets worth ₹ 9,581.32 crores. It’s current offering of mutual fund schemes includes 12 equity, 3 debt and 2 hybrid schemes.
Phone
022-66214999
Email
mfassist@itiorg.com
AUM
₹ 9,581.32 Cr (
As on Jan 2025
)
Address
Naman Midtown “A” Wing, 21st Floor, Senapati Bapat Marg, Elphinstone Road ,Mumbai ,400013

FAQ’S

What is the category of ITI Pharma and Healthcare Fund Direct Growth ?
The category of ITI Pharma and Healthcare Fund Direct Growth is Equity - Sector - Healthcare
What is the current NAV of ITI Pharma and Healthcare Fund Direct Growth ?
The current NAV of ITI Pharma and Healthcare Fund Direct Growth (as on Mar 11, 2025) is ₹ 15.96
How safe is ITI Pharma and Healthcare Fund Direct Growth?
The risk level of ITI Pharma and Healthcare Fund Direct Growth is Very High .
What are short term returns given by ITI Pharma and Healthcare Fund Direct Growth?
The return given by ITI Pharma and Healthcare Fund Direct Growth in 1 month is -3.71%, 3 months is -13.21%, 6 months is -11.28%, and 1 year is 13.33%.
What are the long term returns given by ITI Pharma and Healthcare Fund Direct Growth?
The return given by ITI Pharma and Healthcare Fund Direct Growth in 3 years is 19.34% and 5 years is --.
What is the expense ratio of ITI Pharma and Healthcare Fund Direct Growth?
The expense ratio of ITI Pharma and Healthcare Fund Direct Growth is 0.43 %
What is the AUM of ITI Pharma and Healthcare Fund Direct Growth
The assets under Management (AUM) of ITI Pharma and Healthcare Fund Direct Growth is Rs 216.51 crores.
What is the minimum investment in ITI Pharma and Healthcare Fund Direct Growth?
The minimum Lumpsum investment in ITI Pharma and Healthcare Fund Direct Growth is ₹5000 and the minimum SIP investment in ITI Pharma and Healthcare Fund Direct Growth is ₹1000
What is the asset allocation of ITI Pharma and Healthcare Fund Direct Growth?
The ITI Pharma and Healthcare Fund Direct Growth has an exposure of 93.44% in Equity, and 6.56% in Cash & Money Market Securities

CALCULATORS

Income Tax Calculator SIP Calculator FD Calculator Dividend Yield Calculator Lump-Sum Calculator CAGR Calculator Top-Up Calculator Latte Factor Calculator

Top Stories

Advertisement